G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,540,000 | -22.1% | 474,716 | -50.0% | 0.07% | -18.1% |
| Q3 2020 | $10,966,000 | -52.4% | 949,431 | 0.0% | 0.08% | -60.7% |
| Q2 2020 | $23,033,000 | +120.1% | 949,431 | 0.0% | 0.21% | +49.6% |
| Q1 2020 | $10,463,000 | -58.3% | 949,431 | 0.0% | 0.14% | -55.0% |
| Q4 2019 | $25,093,000 | +16.0% | 949,431 | 0.0% | 0.31% | +5.4% |
| Q3 2019 | $21,628,000 | -25.7% | 949,431 | 0.0% | 0.30% | -54.4% |
| Q2 2019 | $29,110,000 | +84.7% | 949,431 | 0.0% | 0.65% | +48.3% |
| Q1 2019 | $15,761,000 | -13.3% | 949,431 | 0.0% | 0.44% | -41.8% |
| Q4 2018 | $18,182,000 | – | 949,431 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |